# NCT03137771 (NCT03137771)

> Maintenance Chemotherapy With or Without Local Consolidative Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT03137771
- Phase: PHASE2
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: NRG Oncology
- Conditions: Recurrent Non-Small Cell Lung Carcinoma; Stage IV Non-Small Cell Lung Cancer
- Interventions: 3-Dimensional Conformal Radiation Therapy (3D-CRT); Docetaxel; Gemcitabine; Intensity-Modulated Radiation Therapy (IMRT); Pemetrexed Disodium; Stereotactic Body Radiation Therapy (SBRT); Erlotinib Hydrochloride; Pembrolizumab
- Enrollment: 218
- Primary outcome: [Phase II] Progression-free Survival
- Primary outcome: [Phase III] Overall Survival

## Commentary we found

- X threads: 81
- YouTube: 22
- Podcasts: 10

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=nct03137771

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT03137771", "email": "<work email>"}; the inbox owner confirms by the emailed link.